Knowledge Hub - Vaccines & delivery devices

Hot Topic

New vaccine compositions, formulations and combinations have greatly advanced in recent decades. Presently, vaccines are available against 25 diseases, and 12 vaccines are now included in the Expanded Programme on Immunization (EPI), as compared to...

Hot Topic

The widespread use of multi-dose vaccine containers in low- and middle-income countries’ immunization programs is assumed to offer benefits and efficiencies for health systems, such as reducing the purchase price per vaccine dose and easing cold...

No result found

Document

Presentation for NITAGs and Programme managers on the evidence for single dose HPV vaccine schedules

Document

These country-specific resources outline the burden of typhoid (provided by the Global Burden of Disease study) and the potential benefits of new typhoid conjugate vaccines in each country. They are designed to be used by anyone interested in...

Document

Comparison table of WHO prequalified typhoid conjugate vaccines (TCVs).

Document

Ces recommandations sur l’utilisation des vaccins anti-PVH ont été émises par le Groupe stratégique consultatif d’experts sur la vaccination (SAGE) de l’OMS lors de sa réunion d’avril 2022, puis approuvées par l’OMS. Le présent...

Document

Estas recomendaciones provisionales se refieren a la vacuna contra la COVID-19 fabricada por Novavax y el Serum Institute of India a partir de nanopartículas de proteínas recombinantes formuladas con el adyuvante Matrix M por Novavax...

Document

This document explains why gender considerations matter for immunization programming with examples of common gender-related barriers, along with concrete gender-responsive approaches and actions that can be taken to address them. The guide also...

Document

This guide breaks down the development of situation analysis into four well detailed sections. 1. Collection and gathering of data 2. Complete immunization coverage and equity overview 3. Determining barriers and documenting...

Document

This guide is designed to help anyone in the health and immunization system identify and address barriers or leverage drivers to immunization by locally codesigning and evaluating human-centred, tailored immunization programmes. In four stages –...

Document

This position paper discusses the development of the BeSD for vaccine tool. It covers the 4 phases and key activities for the development of the tool. They include: • Initial development of the tool • Field testing • Psychometric...

Document

The guide includes tools and guidance for understanding behavioural and social drivers of vaccination, as well as guidance on how to gather, analyse and use the resuting data. Furthermore, this document includes recommendations on interventions to...

Document

This document includes information on efficacy; WHO prequalification status; safety; mixed schedules and interchangeability of products.

Document

This document is includes information on WHO position on pneumococcal vaccines in infants in children; vaccine characteristics; safety; PCV performance; programmatic considerations; cost and financial considerations; availability and supply;...

Document

The SYSVAC project aims to support National Immunization Technical Advisory Groups (NITAGs) and the World Health Organization Strategic Advisory Group of Experts on Immunization (WHO SAGE) in the development of evidence-based vaccination...

Document

This slide deck includes information on various potential criteria to assess rotavirus vaccines. Those include availability for WHO prequalified rotavirus vaccines supported by Gavi; efficacy, safety and interchangeability; cost, including...

Document

WHO’s Immunization, Vaccines and Biologicals department has developed these sheets within its priority area supporting the introduction of vaccines in Members States. They are primarily designed for use by national public health officials and...

Document

Allows access to up-to-date and comprehensive information on Gavi-supported vaccines (including Rotavirus, PCV, HPV and TCV). Provides an overview of WHO prequalified products for the vaccine groups that Gavi supports. The easy access to data aims...

Document

Provides an overview of the most recent and historical data on GAVI supported vaccine products that UNCIEF procures on behalf of countries. Provides information on vaccine, form, presentation, number of awarded manufacturers, storage space...

Document

This simulation model can serve as a 'virtual laboratory' for decision-makers helping to answer what will be the impact of introducing new technologies (vaccines), what may be the effects of altering the characteristics of vaccines and other...

Document

The survey has 4 broad groups of questions: what is the availability of different health services in a country, specifically what proportions of the different facility types offer specific health services; to what extent are facilities prepared to...

Document

The OneHealth Tool attempts to link strategic objectives and targets of disease control and prevention programmes to the required investments in health system. The tool provides planners with a single framework for scenario analysis, costing, health...

Document

The website provides the latest data availble at the WHO. It includes a wide range of data types and different presentations. Some of the featured data sets include: global health estimates, mortality database, health SDGs, triple billion target,...

Document

Nationally representative household survey that provides data for wide range of monitoring and impact evaluation indicators in the areas of population, health and nutrition.

Document

The IDCC is a comprehensive, and standardized global evidence on the cost of delivering vaccines. The Immunization Delivery Cost Catalogue (IDCC) was built to answer a question frequently asked by national and global immunization stakeholders:...

Document

The WHO website provides a list of certain diseases for which vaccines are available, and a list of some pathogens for which vaccines and/or monoclonal antibodies (mAbs) are in development. For each disease or pathogen, a link is provided to a...

Document

The list is not an exhaustive list of vaccines used to immunize humans. It reflects those vaccines which, following a selection based on immunization priorities set by relevant UN agencies and WHO, have been submitted to WHO for evaluation by...

Document

The Consortium aims to deliver a more sustainable, efficent, and transparent approach to generating disease burden and vaccine impact estimates. It works on aggregating the estimates across a protfolio of 12 vaccine-preventable diseases and further...

Document

Allows to browse data along actual datasets. Provides information on the global burden of diseases (globally, regionally, by country and by region). Provides country datasets for the burden of disease and access to health, as well demographic data....

Document

UNIVAC is a single universal vaccine impact and cost-effectiveness decision support model with a standardized, accessible Excel-based (now based in R), interface and a familiar set of input steps and outputs. Input estimates of age-specific disease...

Document

This background document has been prepared by the SAGE working group on smallpox and monkeypox vaccines to inform the discussions of SAGE at its 3-7 October 2022 meeting.

Document

Document

Estas recomendaciones provisionales1 se refieren a la vacuna mRNA-1273, fabricada por Moderna, que también se conoce como vacuna anti-COVID-19 de Moderna. En algunos países la vacuna se comercializa con el nombre de «Spikevax». En adelante, en...

Document

This Good Practice Statement summarizes current evidence on these variant-containing mRNA vaccines and provides guidance on their use in the context of the continued availability of ancestral virus-based COVID-19 vaccines. The recommendations apply...

Document

Le présent document remplace la précédente note de synthèse sur les vaccins anti-hépatite A, publiée par l’OMS en 2012. Il contient des recommandations sur l’utilisation hors indications de ces vaccins.

Document

This document replaces the 2012 WHO position paper on hepatitis A vaccines. It contains off-label recommendations.

Document

Recomendaciones provisionales para el uso de la vacuna de Valneva (‎VLA2001)‎ contra la COVID-19: orientaciones provisionales, versión inicial: 18 de agosto de 2022

Document

Recommandations provisoires concernant l’utilisation du vaccin de Valneva (‎VLA2001)‎ contre la COVID-19 : orientations provisoires, première publication : 18 août 2022

Document

Recomendaciones provisionales sobre el uso de la vacuna BNT162b2 de Pfizer y BioNTech contra la COVID-19 en el marco de la Lista OMS de uso en emergencias: orientaciones provisionales, primera publicación: 8 de enero de 2021, actualización: 15 de...

Document

Analyse de la réponse du pays à la COVID-19 et identification des meilleures pratiques et des lacunes cruciales à prendre en compte dans les futurs plans d’intervention,Analyse de la réponse du pays à la COVID-19 et identification des...

Document

The vaccine tracker was developed by World Bank in an effort to identify countries in urgent need of financial and operational support for vaccine deployment readiness, and to monitor, track and resolve bottlenecks on the ground.,The vaccine tracker...

Document

This is a link to a set of posts on vaccine introduction, supply chain and storage planning, and communication with communities,This is a link to a set of posts on vaccine introduction, supply chain and storage planning, and communication with...

Document

This is a link to a post on how to generate demand for Covid-19 vaccination,This is a link to a post on how to generate demand for Covid-19 vaccination

Document

This is Rockefeller microsite on Covid-19 vaccine particularly focusing on increasing demand and accelerating global equity,This is Rockefeller microsite on Covid-19 vaccine particularly focusing on increasing demand and accelerating global equity

Document

Analyse de la situation de vaccination contre la COVID-19 en RDC et stratégies de couverture des personnes les plus vulnérables,Analyse de la situation de vaccination contre la COVID-19 en RDC et stratégies de couverture des personnes les plus...

Document

Revue sur l'expérience du Rwanda en matière de mise à l’échelle de méthodes de suivi en temps réel et d’utilisation de solutions numériques pour renforcer la surveillance de la COVID-19, la vaccination contre la COVID-19 et la gestion des...

Document

Highlighting Rwanda’s Experience Scaling Real-time Monitoring Approaches Using Digital Solutions to Support COVID-19 Surveillance, COVID-19 Vaccination and Case Management,Highlighting Rwanda’s Experience Scaling Real-time Monitoring Approaches...

Document

Leasons learned on vaccination against COVID-19,Leasons learned on vaccination against COVID-19

Document

Evaluation of CPIE,Evaluation of CPIE

Document

India: Description de la plateforme électronique de vaccination contre la COVID-19 pour l’enregistrement et la déclaration ,India: Description de la plateforme électronique de vaccination contre la COVID-19 pour l’enregistrement et la...

Document

RDC: Analyse de la réponse du pays à la COVID-19 et identification des meilleures pratiques et des lacunes cruciales à prendre en compte dans les futurs plans d’intervention,RDC: Analyse de la réponse du pays à la COVID-19 et identification...

Document

Guinée Bissau: Analyse de la réponse du pays à la COVID-19 et identification des meilleures pratiques et des lacunes cruciales à prendre en compte dans les futurs plans d’intervention pratiques exemplaires.,Guinée Bissau: Analyse de la...

Events

Findings from a healthcare worker evaluation of the COVID-19 vaccine label

May 08th 2021

PATH’s Living Labs Initiative used human-centered design methods to gather feedback on prop

Events

Powering Vaccine R&D: A Discussion on the Future of the Global Vaccine R&D Ecosystem

April 29th 2021

Join this webinar for a panel discussion and Q&A reflecting on ideas offered in a forthcoming report by the Sabin-Aspen Vaccine Science & Policy Group, Powering Vaccine R&D: Opportuniti

Events

New single-dose HPV vaccination evidence and resources

March 26th 2021

The Single-dose HPV Vaccine Evaluation Consortium collates and synthesizes existing evidence and evaluates new data on the potential for single-dose HPV vaccination. Their goal is to inform global

Events

Vaccines and Antimicrobial Resistance

March 16th 2021

A live webinar organised by CDDEP, in collaboration with the WHOHow can vaccines address the problem with AMR?SPEAKERS:Dr. Hanan Balkhy, Assistant-Dir

Events

SARS-CoV-2 Variants and the Safety of COVID-19 Vaccines in the U.S.

March 16th 2021

The International Vaccine Access Center (IVAC) on March 23, 2021 at 11:00am ET will host a 60-minute webinar SARS-CoV-2 Variants and the Safety of COVID-19 Vaccines in the U.S.

Events

TechNet Conference: How changing vial size can improve your immunization services

October 06th 2020

With COVID demanding smaller session sizes, it is more important than ever to consider smaller vaccine vial size to better tailor to session sizes.This presentation will share results from an imple

Events

Events

WHO-UNICEF-IPA Webinar on Immunization during COVID-19 Pandemic

May 12th 2020

Join the second seminar jointly organized by WHO-UNICEF-IPA.This is part of a series of webinars that will be organized jointly for the next 6-8 months to disseminate guidance and a provide new inf

Events

Immunization in the Time of COVID-19

May 11th 2020

We hope you can join us online on Thursday 14th May 2020, 15h00 (CET) [14:00 UK time] for a webinar hosted by the Gavi CSO Constituency & partners, as immunisation and communit

Events

Webinar - UAV Procurement Guide - UAVs for Payload Delivery Working Group

July 20th 2018

Presentation of the "UAV Procurement Guide" by USAID Global Health Supply Chain Program - Procurement and Supply Management (GHSC-PSM) project The guidelines are available here: https://www.ghsuppl

Events

Vaccines & Clinical Trials

December 05th 2017

Vaccines & Clinical Trials 2018 will discuss various disciplines involved in the vaccines research; it will educate health care researchers about design, operation, organizing, and research computing,

Events

30th Euro Global Summit and Expo on Vaccines and Vaccination

July 06th 2017

Theme: Roadmap on the future of Vaccines Research, Barcelona, Spain http://vaccines.global-summit.com/europe/

Events

29th International Conference on Vaccines and Immunization

July 06th 2017

Theme: Highlights of latest technologies and innovations in Vaccines and Immunization http://vaccines-immunization.conferenceseries.com/

Events

The Sixth ESWI Influenza Conference

June 26th 2017

The European Scientific Working group on Influenza (ESWI) is looking forward to organizing the sixth edition of its ESWI Influenza Conferences in Riga, Latvia, on 10 – 13 September 2017. Over the pa

Events

World Vaccines Congress

June 26th 2017

Like its US and European counterparts, the World Vaccine Congress India will bring together leading in-country vaccine manufacturers, including Serum Institute of India, Biological E, Shantha, Cipla,

Events

DCVMN Training Workshop - Vaccine Safety and Pharmacovigilance Strategies

March 20th 2017

Developing Countries Vaccine Manufacturers Network (DCVMN) Training Workshop in Vaccine Safety and Pharmacovigilance Strategies.

Events

HSV Vaccine Preferred Product Characteristics Global Stakeholder Consultation

February 23rd 2017

HSV Vaccine Preferred Product Characteristics Global Stakeholder Consultation

Events

AAP 2017 HPV Vaccination Update

February 21st 2017

Interested in learning what the new HPV vaccination series recommendations means for your practice? Unsure of how to best address commonly asked questions about HPV vaccinations from parents? Want to

Events

Skin Vaccination Summit

January 31st 2017

Recognition of the skin by vaccinologists as an ideal anatomical target has gathered momentum in the past decade. The premise that the dense population of APCs can be targeted, stimulated and loaded w

Events

22nd Global Vaccines & Vaccination Summit

January 23rd 2017

Theme: Innovative Therapeutic Strategies in Vaccines & Vaccination Track 1: Vaccine development: Vaccine research is long, complex and costly. Because a vaccine is a biological product made from l

Events

18th Global Summit & Expo on Vaccines & Vaccination

January 23rd 2017

Theme: A New Era in Vaccines research & Development. Topics: Recombinant vector vaccines, Subunit vaccines, conjugate Vaccines, Inactivated/Killed Vaccines, Experimental Vaccines, Valence Vaccines, He

Events

International Conference on Vaccine Design, Production & Safety

January 23rd 2017

Deliberation on modern vaccine research and development focusing on vaccine design, delivery and evaluation

Events

International Conference on Vaccine Adjuvants and Delivery Technologies

January 23rd 2017

Theme: Discussion on latest research and technologies in Vaccine adjuvants & delivery systems

Events

16th Euro Global Summit and Expo on Vaccines & Vaccination

January 23rd 2017

Theme: “Accelerating Next Generation Vaccines for Global Health”

Events

15th Annual Summit on Vaccines and Immunization

January 23rd 2017

Theme: Discussion on Novel research technologies and practical challenges in Vaccination

Events

Fifth Measles Virus mini symposium

December 21st 2016

Fifth Measles Virus mini symposium

 

Vaccine Vial Monitor (VVM)-based vaccine management

This TechNet-21 webinar on vaccine vial monitor (VVM)-based vaccine management was given on the occasion of the publishing of “The Book of VVM: Yesterday-today-and-tomorrow” by Umit Kartoglu. During this webinar, the presenters discussed the...

Des patchs à micro-aiguilles pour administrer les vaccins contre la rougeole et la rubéole ? (16ème Conférence TechNet)

Les vaccins contre la rougeole et la rubéole sont sûrs et efficaces, mais la couverture équitable, en particulier pour la deuxième dose de vaccin contenant la rougeole (MCV2), est bien inférieure à l'objectif de 95% d'enfants vaccinés. En...

How, where and when are we going to use microarray patches to deliver measles and rubella vaccines? (16th TechNet Conference)

Measles and rubella vaccines are safe and effective, however, achieving equitable coverage, particularly for the second dose of measles containing vaccine (MCV2) is well below the 95% target of immunized children. Consequently, there were over...

Findings from a healthcare worker evaluation of the COVID19 vaccine label

PATH’s Living Labs Initiative used human-centered design methods to gather feedback on proposed labels for COVID-19 vaccine vials and cartons. Healthcare workers in Kenya and Zambia interacted with the labels and made recommendations for vaccine...